![](https://webarchive.library.unt.edu/eot2008/20081004165504im_/http://cancernet.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081004165504im_/http://cancernet.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081004165504im_/http://cancernet.nci.nih.gov/images/spacer.gif)
| The first step in testing a new treatment in humans. These studies test the best way to give a new treatment (for example, by mouth, intravenous infusion, or injection) and the best dose. The dose is usually increased a little at a time in order to find the highest dose that does not cause harmful side effects. Because little is known about the possible risks and benefits of the treatments being tested, phase I trials usually include only a small number of patients who have not been helped by other treatments. |
![](https://webarchive.library.unt.edu/eot2008/20081004165504im_/http://cancernet.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081004165504im_/http://cancernet.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081004165504im_/http://cancernet.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081004165504im_/http://cancernet.nci.nih.gov/images/spacer.gif) |